多中心背景下基于MRI的影像组学特征对导管原位癌风险分层的价值(ECOG-ACRIN E4112试验)
本研究为ECOG-ACRIN E4112试验的二次分析,纳入297例女性导管原位癌患者,利用临床信息和MRI影像组学特征构建逻辑回归模型,预测手术升级和DCIS评分。结果发现两种影像组学表型与疾病升级相关(P=0.007),联合临床和定性MRI特征预测疾病升级的AUC最高为0.77(95%CI:0.65,0.88),较单用临床信息识别出更多真阴性(49/93,特异度53% vs 23/93,28%)。影像组学模型对DCIS评分无预测价值(P>0.05)。
要点
- 联合影像组学与临床信息预测DCIS手术升级的AUC达0.77(95%CI:0.65,0.88),优于单用临床信息。
- 影像组学模型未显示对DCIS评分有预测价值(P>0.05)。
- 识别出两种与疾病升级相关的影像组学表型(P=0.007)。
核心结论
- 在DCIS患者中,影像组学指标联合临床信息可改善对疾病升级的预测,但不能预测DCIS评分。
研究设计与样本
- ECOG-ACRIN E4112试验的二次分析,分析动态对比增强MRI数据,主要分析预测疾病升级(n=295),次要分析预测DCIS评分(n=174),共纳入297例女性参与者(中位年龄60岁,IQR 51-67岁),使用放射科医生勾画的病灶分割和公开可用的CaPTk软件计算65个影像组学特征,数据按3:2比例分为训练集和测试集。
诊断标准与关键数值
- 预测疾病升级时,排名前三的影像组学主成分联合临床和定性MRI预测因子在所有测试模型中AUC最高,为0.77(95%CI:0.65,0.88),P=0.007;该模型识别出49/93真阴性(特异度53%),较单用临床信息(23/93真阴性,特异度28%)识别出25%更多真阴性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Ductal carcinoma in situ (DCIS) is a nonlethal, preinvasive breast cancer for which breast MRI is best suited for accurate disease extent characterization. DCIS is often overtreated, necessitating robust models for improved risk stratification. Purpose To develop logistic regression models using clinical and MRI-based radiomic features of DCIS and to evaluate the performance of such models in predicting disease upstaging at surgery and DCIS score. Materials and Methods This study is a secondary analysis of dynamic contrast-enhanced (DCE) MRI data from the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, or ECOG-ACRIN, E4112 trial. Primary analysis focused on predicting disease upstaging (n = 295), and secondary analysis focused on predicting DCIS score (n = 174). Radiologist-drawn lesion segmentations and publicly available Cancer Phenomics Toolkit, or CaPTk, software was used to compute 65 radiomic features. Participants were clustered into groups based on their radiomic features (ie, radiomic phenotypes), and principal component analysis was used to summarize the feature space. Clinical information and qualitative MRI features were available. Associations were tested using χ2 and likelihood ratio tests. Data were split into training and test sets with a 3:2 ratio, and model performance was assessed on the test set using the area under the receiver operating characteristic curve (AUC). Results Data from 297 female participants with median age of 60 years (IQR, 51-67 years) were analyzed. Two radiomic phenotypes were identified that were associated with disease upstaging (P = .007). For predicting disease upstaging, the top three radiomic principal components combined with clinical and qualitative MRI predictors yielded the highest AUC of 0.77 (95% CI: 0.65, 0.88) among all tested models (P = .007), identifying 25% more true-negative (49 of 93 true-negative findings, 53% specificity) findings, compared with using clinical information alone (23 of 93 true-negative findings, 28% specificity). Radiomic models were not predictive of the DCIS score (P > .05). Conclusion In patients with DCIS, combining radiomic metrics with clinical information improved prediction of disease upstaging but not DCIS score. ClinicalTrials.gov Identifier: NCT02352883 Supplemental material is available for this article. ©RSNA, 2025 See also the editorial by Kim and Woo in this issue.
引用
- Slavkova KP, Kang R, Kazerouni AS, et al. MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial). Radiology. 2025. PMID: 40167440. doi:10.1148/radiol.241628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。